FDA Approves Pump For Patients Awaiting Heart Transplants
Yesterday, the U.S. Food and Drug Administration approved the HTWR, HIN.AU, a heart-pump for heart patients awaiting heart transplants. This is welcome news for more than five million heart patients in the U.S., 150,000 with severe heart failure, awaiting heart transplants with a limited supply of hearts available. The pump, created by HeartWare International Inc., […]
2 min read